Загрузка...
Anti-VEGF Therapies in the Clinic
The development and use of antiangiogenesis agents, particularly those targeting vascular endothelial growth factor (VEGF), has become an integral component of anticancer regimens for many tumor types. This review is intended to highlight some of the most important clinical successes and failures of...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cold Spring Harbor Laboratory Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3475399/ https://ncbi.nlm.nih.gov/pubmed/23028128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a006577 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|